SRPT vs YUMC · rev $1.13B vs P/E 19, rev $6.41B
Sarepta Therapeutics Inc (SRPT) versus Yum China Holdings Inc (YUMC) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Yum China Holdings Inc (YUMC) is a restaurants company listed on US.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Latest reported YUMC revenue for 2026-06-30 was $6.41B. Net income was $553.0M. Revenue was up 95.9% from 2026-03-31 to 2026-06-30. YUMC currently screens at market cap $16.96B and trailing P/E 19.1.
SRPT currently screens at market cap $2.34B. YUMC currently screens at market cap $16.96B and trailing P/E 19.1.
Not investment advice. Open the SRPT and YUMC stock pages for the full models.
Not investment advice.